| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 65.090 | 36.589 | 46.345 | 52.472 | 34.129 |
| Total Income - EUR | - | - | - | - | - | 65.091 | 36.591 | 46.345 | 52.472 | 34.129 |
| Total Expenses - EUR | - | - | - | - | - | 87 | 4.269 | 12.242 | 48.692 | 33.459 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 65.004 | 32.322 | 34.103 | 3.780 | 671 |
| Net Profit/Loss - EUR | - | - | - | - | - | 63.079 | 31.467 | 32.862 | 1.901 | 205 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Elc Epimed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 35.804 | 34.939 | 30.869 |
| Current Assets | - | - | - | - | - | 64.796 | 31.628 | 17.542 | 21.649 | 24.794 |
| Inventories | - | - | - | - | - | 0 | 3.106 | 3.116 | 3.106 | 3.089 |
| Receivables | - | - | - | - | - | 36.926 | 27.809 | 13.498 | 13.660 | 20.957 |
| Cash | - | - | - | - | - | 27.871 | 713 | 927 | 4.883 | 749 |
| Shareholders Funds | - | - | - | - | - | 63.120 | 31.553 | 53.816 | 55.553 | 55.448 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 1.676 | 75 | 75 | 1.035 | 215 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Elc Epimed S.r.l.